CER Daily Newsfeed

Philips Launches Real-World Study of Low-Dose X-Ray in Coronary Procedures

(5/20, Sean Whooley, MassDevice) reports “...According to Dr. Javier Escaned, a professor of cardiology at Hospital Clínico San Carlos and the study’s principal investigator, the study aims to reduce radiation exposure without compromising procedural performance in interventional cardiology. Escaned hopes RADIQAL generates robust real-world evidence on Philips’ ultra-low X-ray dose technology. Investigators intend to evaluate if it can reduce radiation exposure for patients and staff without affecting the quality of coronary procedures.” Full

Spain Beats England To Tevimbra Reimbursement Recommendations

(5/20, Francesca Bruce, Pink Sheet) reports “BeiGene’s PD-1 inhibitor, Tevimbra (tislelizumab), has been okayed for reimbursement on the Spanish national health system (SNS), according to a pricing and reimbursement report from CIPM, Spain’s Interministerial Commission on Drug Prices.” Subscription Required

Cordis Initiates SELUTION Global Coronary Registry of Coronary DCB

(5/20, Cardiovascular News) reports “...‘Drug-eluting balloons are one of the most interesting and exciting new technologies in the coronary interventional space,’ said Ajay J Kirtane (Columbia University Irving Medical Center, New York, USA). ‘The creation and initiation of this large real-world registry examining drug-eluting balloon utilisation and the practice of percutaneous coronary intervention (PCI) with this technology is a welcome development, which will help clinicians better understand where SELUTION SLR drug-eluting balloon can deliver the greatest benefits and improved outcomes in their practice.’” Full

Real-World Evidence Links Long-Term Use of Oral and Inhaled Steroids to Adrenal Insufficiency

(5/20, Dr. Kamal Kant Kohli, Medical Dialogues) reports “...The researchers found that those who used steroid tablets for more than 3 months were over 6 times more likely to be diagnosed with adrenal insufficiency and over 3 times more likely to be hospitalised for adrenal insufficiency than those who only used NSAIDs. Similarly, those who took inhaled steroids had a 55% higher risk of being diagnosed with adrenal insufficiency, but did not have an increased risk of being hospitalised for the same condition.” Full

CGH and Hologic Ink MoU on Breast Imaging Research and Education

(5/21, Healthcare Asia) reports “Singapore's Changi General Hospital (CGH) has signed a memorandum of understanding with Hologic, Inc. to collaborate on breast imaging research and education. Both organisations will focus on the co-development of real-world evidence for imaging technologies to improve cancer detection and clinical outcomes.” Full